Chemed Corp (CHE) Covered Calls

Chemed Corporation is a diversified holding company that operates two premier wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation’s largest provider of end-of-life hospice care, while Roto-Rooter is the leading provider of plumbing, drain cleaning, and water restoration services. By combining stable healthcare revenue with the high-margin, recession-resistant demand of residential services, the firm delivers consistent value.

You can sell covered calls on Chemed Corp to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CHE (prices last updated Wed 4:16 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

Chemed Corporation (CHE) occupies a unique niche in the American economy, operating as a decentralized holding company for two market-leading service brands: VITAS Healthcare and Roto-Rooter. Headquartered in Cincinnati, Ohio, the firm leverages a capital-allocation-driven corporate office that manages strategic planning and investment while allowing its subsidiaries to operate with high autonomy. This dual-segment model provides investors with exposure to both the secular growth of healthcare and the cyclical resilience of professional home services.

2026 Strategic Moves and Roto-Rooter Acquisitions

The first half of 2026 has been marked by aggressive capital deployment. On April 1, 2026, the company announced that its Roto-Rooter subsidiary completed the acquisition of two major franchise territories in San Francisco, California, and Fort Worth, Texas. These acquisitions are part of a long-term strategy to consolidate the Roto-Rooter system under corporate ownership to enhance margins and service consistency. Additionally, in February 2026, the Board of Directors authorized an additional $300 million for stock repurchases, highlighting a robust balance sheet that remains debt-free.

Operationally, VITAS Healthcare continues to navigate the post-pandemic labor environment with improved clinician retention and an Average Daily Census (ADC) that reached 22,462 in early 2026. The segment is benefiting from a geographically weighted average Medicare reimbursement rate increase of approximately 2.2%. Despite slight margin pressure in late 2025 due to higher labor costs, the integration of new digital scheduling tools at Roto-Rooter and increased admissions at VITAS are expected to drive high-single-digit earnings growth through the remainder of 2026.

Competitive Landscape

Chemed competes across two distinct industries, requiring a comparison with both large-cap healthcare providers and specialized facility service firms. Key competitors include:

1. Humana Inc.: A leading healthcare company with a significant presence in home health and hospice via CenterWell. They compete directly with VITAS for market share in senior care, providing a highly liquid, optionable benchmark for the healthcare segment.
2. UnitedHealth Group Inc.: Through its Optum segment, UNH is a dominant force in home-based care. They compete for similar patient populations and payer contracts, offering the primary large-cap valuation metric for the hospice industry.
3. Encompass Health Corporation: A major provider of post-acute healthcare services. They compete in the broader home-based and rehabilitative care market and maintain a highly liquid options chain, making them a preferred peer for volatility and income strategies.
4. Rollins, Inc.: The parent company of Orkin. While focused on pest control, Rollins is the closest pure-play peer for Roto-Rooter in terms of a national, recession-resistant residential service model with high brand equity and an active options market.

Strategic Outlook and Shareholder Value

The firm is prioritizing "Digital Operational Alpha" in late 2026, particularly at Roto-Rooter, where predictive dispatching and water-restoration cross-selling are driving higher revenue per technician. Strategic efforts at VITAS are focused on expanding into under-penetrated markets such as Pennsylvania and Georgia, following the successful staffing ramp-up in the Florida and California regions. The company maintained its quarterly dividend of $0.60 per share in early 2026, reflecting its 54-year history of consistent payouts.

Looking toward 2027, Chemed is positioned to benefit from the aging U.S. population and the increasing consumer preference for "Do-It-For-Me" home services. Management’s disciplined approach to M&A—focusing on franchise re-acquisitions—is expected to provide a reliable floor for valuation. As of April 2026, with no long-term debt and a price-to-earnings ratio stabilizing around 18x, the company remains a defensive staple for investors seeking high-quality earnings with a low-volatility profile.

Want more examples? CHDN Covered Calls | CHEF Covered Calls